Antitumoral effects of cannabis in Notch1 ‐mutated T‐cell acute lymphoblastic leukemia
Open Access
- 21 April 2023
- journal article
- letter
- Published by American Association for the Advancement of Science (AAAS) in Cancer Communications
- Vol. 43 (6) , 711-715
Abstract
No abstract availableFunding Information
- Israel Cancer Research Fund (21‐112‐PG)
- Israel Cancer Research Fund (21‐112‐PG)
This publication has 10 references indexed in Scilit:
- Cannabis for Medical Use: Versatile Plant Rather Than a Single DrugFrontiers in Pharmacology, 2022
- The heterogeneity and complexity of Cannabis extracts as antitumor agentsOncotarget, 2019
- THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIESMediterranean Journal of Hematology and Infectious Diseases, 2019
- Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancerBiochemical Pharmacology, 2018
- A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in CannabisScientific Reports, 2018
- New approaches and challenges to targeting the endocannabinoid systemNature Reviews Drug Discovery, 2018
- T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignanciesBlood Reviews, 2018
- The Antitumor Activity of Plant-Derived Non-Psychoactive CannabinoidsJournal of Neuroimmune Pharmacology, 2015
- Towards the use of cannabinoids as antitumour agentsNature Reviews Cancer, 2012
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011